BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.69B |
| 2 |
Apple
AAPL
|
+$892M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$799M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$793M |
| 5 |
GE Aerospace
GE
|
+$748M |
Top Sells
| 1 |
Tesla
TSLA
|
+$362M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$345M |
| 3 |
NVIDIA
NVDA
|
+$258M |
| 4 |
MetLife
MET
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| 1 | Technology | 26.74% |
| 2 | Consumer Discretionary | 11.23% |
| 3 | Financials | 10.63% |
| 4 | Healthcare | 8.41% |
| 5 | Communication Services | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Amylyx Pharmaceuticals
AMLX
$1.05B
| $4.34K | ﹤0.01% |
+1,149
| New | +$4.34K |
|
3927
KORU Medical Systems
KRMD
$187M
| $4.34K | ﹤0.01% |
+1,128
| New | +$4.34K |
|
3928
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.15B
| $4.32K | ﹤0.01% |
93
-1,616
| -95% | -$75K |
|
3929
Gores Guggenheim
PSNY
$2.02B
| $4.3K | ﹤0.01% |
+4,094
| New | +$4.3K |
|
3930
Deswell Industries
DSWL
$68M
| $4.28K | ﹤0.01% |
1,800
-2,100
| -54% | -$5K |
|
3931
Emergent Biosolutions
EBS
$425M
| $4.25K | ﹤0.01% |
445
-31,025
| -99% | -$297K |
|
3932
Haleon
HLN
$44B
| $4.25K | ﹤0.01% |
+445
| New | +$4.25K |
|
3933
Principal Spectrum Preferred Securities Active ETF
PREF
$1.29B
| $4.17K | ﹤0.01% |
224
+43
| +24% | +$800 |
|
|
IVA
3934
Inventiva
IVA
$769M
| $4.07K | ﹤0.01% |
+1,900
| New | +$4.07K |
|
3935
LifeVantage
LFVN
$143M
| $4.05K | ﹤0.01% |
231
| – | – |
|
3936
Socket Mobile
SCKT
$8.12M
| $3.99K | ﹤0.01% |
3,001
| – | – |
|
3937
Vanguard Global ex-US Real Estate ETF
VNQI
$3.59B
| $3.96K | ﹤0.01% |
100
| – | – |
|
|
ELEV
3938
DELISTED
Elevation Oncology
ELEV
| $3.9K | ﹤0.01% |
+6,923
| New | +$3.9K |
|
3939
Richmond Mutual Bancorp
RMBI
$140M
| $3.88K | ﹤0.01% |
+274
| New | +$3.88K |
|
3940
Prairie Operating Co
PROP
$104M
| $3.81K | ﹤0.01% |
550
-1,346
| -71% | -$9.31K |
|
3941
Schwab US TIPS ETF
SCHP
$14.1B
| $3.75K | ﹤0.01% |
145
+13
| +10% | +$336 |
|
3942
Alto Ingredients
ALTO
$89M
| $3.68K | ﹤0.01% |
+2,360
| New | +$3.68K |
|
3943
Veritone
VERI
$201M
| $3.59K | ﹤0.01% |
1,094
+38
| +4% | +$125 |
|
3944
Aclaris Therapeutics
ACRS
$221M
| $3.59K | ﹤0.01% |
1,446
-1,822
| -56% | -$4.52K |
|
3945
Bakkt Holdings
BKKT
$150M
| $3.54K | ﹤0.01% |
143
-176
| -55% | -$4.36K |
|
3946
Gevo
GEVO
$392M
| $3.49K | ﹤0.01% |
1,669
-7,526
| -82% | -$15.7K |
|
3947
VanEck BDC Income ETF
BIZD
$1.67B
| $3.43K | ﹤0.01% |
206
+84
| +69% | +$1.4K |
|
3948
iShares MSCI EAFE Growth ETF
EFG
$13.3B
| $3.39K | ﹤0.01% |
35
-29
| -45% | -$2.81K |
|
|
TBNK
3949
DELISTED
Territorial Bancorp Inc.
TBNK
| $3.38K | ﹤0.01% |
+347
| New | +$3.38K |
|
3950
Palladyne AI
PDYN
$287M
| $3.28K | ﹤0.01% |
267
+2
| +0.8% | +$25 |
|